Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

September 30, 2006

Conditions
Type II Diabetes MellitusMixed Dyslipidemia
Interventions
DRUG

fenofibrate 160 mg and placebo

DRUG

simvastatin 20 mg and placebo

DRUG

fenofibrate 160 mg and simvastatin 20 mg

Trial Locations (2)

84143

LDS Hospital, Salt Lake City

84403

McKay Dee Hospital, Ogden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Intermountain Health Care, Inc.

OTHER